Dermatology Payer Mix: Medical vs. Cosmetic Revenue and Lenders
Dermatology payer mix describes where a practice’s revenue comes from: commercial insurers, Medicare, Medicaid and patients paying cash for cosmetic services. Dermatology practices can have a wide range of possible mixes, and that mix shapes how lenders and buyers view the practice’s risk.
This article explains how different revenue sources behave and why the balance matters when you seek financing or plan a sale. Payer rules and reimbursement vary, and nothing here is billing, coding, compliance, legal or tax advice. Practices should work with qualified billing or compliance professionals and accountants.
The Main Revenue Sources in Dermatology
- Commercial insurers: medical visits, procedures and pathology covered by private plans
- Medicare: often a significant source for practices treating older patients, including skin cancer care
- Medicaid: varies widely by practice and region
- Cosmetic cash pay: injectables, lasers, peels and other elective services paid directly by patients
- Retail: skincare products sold in the office
Many practices also generate revenue from ancillary services such as Mohs surgery or in-house pathology, which are typically billed to payers.
How Medical Revenue Behaves
Insured medical revenue tends to be driven by patient need. Skin cancer screenings, chronic conditions and surgical care may bring patients back across different economic conditions. That can support steady volume.
It also comes with constraints. Reimbursement is set by payer contracts and fee schedules, payments arrive after claims are processed and denials or audits can affect collections. Policy changes can affect reimbursement in ways the practice does not control.
How Cosmetic Revenue Behaves
Cosmetic revenue is paid at the time of service, which can help cash flow. Margins on some services may be attractive, and pricing is set by the practice rather than a payer.
At the same time, cosmetic demand can be more sensitive to economic conditions, competition and marketing. It often depends on specific providers and devices, and it may require ongoing investment to stay competitive. Practices that build a significant aesthetic business may want to read about how to add a med spa to a dermatology practice.
Why Dermatology Payer Mix Matters to Lenders
Lenders generally want to understand whether revenue will continue after a loan closes. When reviewing a dermatology payer mix, they may ask:
- How diversified is revenue across payers and service lines?
- Is any single payer or service responsible for a large share of collections?
- How has cosmetic revenue held up over several years?
- Does cosmetic revenue depend on one provider or one device?
- How long does it take to collect insured claims?
A balanced mix can reassure lenders that the practice is not overly exposed to one source. Our guide to what lenders look for when financing a dermatology practice covers the other factors involved.
Why It Matters to Buyers
Buyers evaluating a practice often adjust their view of value based on the mix. Medical revenue tied to a stable patient base may be seen as durable. Cosmetic revenue may be viewed favorably if it is spread across several providers and has a consistent history, and more cautiously if it depends on the selling physician.
Our guide on how to value a dermatology practice before buying explains how revenue quality feeds into valuation, and our article on dermatology practice EBITDA covers how earnings are measured.
Payer Mix and Cash Flow Timing
The mix also affects when cash arrives. Cosmetic payments are collected at the visit, while insured claims are paid only after they are processed. A practice heavy in insured revenue may need more working capital to cover the gap, especially during credentialing changes or after an acquisition.
A dermatology line of credit is one tool some practices use to smooth those timing differences.
How to Present Your Payer Mix
When applying for financing or preparing for a sale, clear reporting helps. Consider assembling:
- Collections by payer category over several years
- Collections by service line, separating medical, surgical, cosmetic and retail
- Revenue by provider
- Accounts receivable aging by payer
- Notes explaining any major shifts, such as a new provider or device
Strategies to Strengthen the Mix
- Spread cosmetic services across more than one trained provider, subject to state supervision rules
- Review payer contracts periodically with qualified professionals
- Monitor denial and collection trends
- Track cosmetic patient retention, not just new patients
- Avoid adding devices without a clear demand plan
Payer Mix After an Acquisition
A buyer’s payer mix can shift after closing. Some patients may follow the departing physician, cosmetic clients may test the new provider before returning and payer enrollments may need to be updated. Payer contracts and Medicare and Medicaid enrollments should not be assumed to transfer, so collections can be uneven during the transition.
Buyers who understand the seller’s mix in detail can plan for these changes, set realistic projections and build enough reserves into their financing. Lenders may also view a buyer more favorably when the transition plan addresses each revenue stream directly.
No Single Ideal Mix
There is no correct balance that suits every practice. A medically focused practice in an older community and a cosmetic-heavy practice in a metropolitan area can both perform well. What matters to lenders and buyers is that the mix is understood, documented and supported by consistent results.
Final Thoughts
Dermatology payer mix influences cash flow timing, perceived risk and what a practice may be worth. Understanding how medical and cosmetic revenue behave, and presenting that information clearly, can help owners have stronger conversations with lenders and buyers.
US Medical Funding helps dermatology practices finance acquisitions, expansion and working capital needs. Learn more about our dermatology practice financing options.
